River(hot)Babe,
Please look at NYMX and TITFX.pk for me.
Tell me what you see.
RiverBabe's Baby Biotechs
Collapse
X
-
River,
I think MNKD's Afrezza will win approval but I still won't take a chance on it. My conservative stance on stocks has worked out too well this year to blow it now.
----------billy
Leave a comment:
-
-
shee-ee-ee-$t!! P.S. it only hurts when you think about it, so time to stop thinking.Originally posted by billyjoe View Post
Leave a comment:
-
-
Geez Loueez, what an ugly chart! (Dec 6/10) Insmed Incorporated , a biopharmaceutical company, announced today that it has entered into a business combination, effective immediately, with Transave, Inc., a privately-held, NJ-based biopharmaceutical company focused on the development of differentiated, innovative inhaled pharmaceuticals for the site-specific treatment of serious lung infections.Originally posted by Peter Hansen View PostRiver what do you know about INSM Insmed Inc ? Took a beating after an 8K filing with the SEC, BUT INSM is coming alive .....I smell some money can be made at .595 cents per share here on way back up to 70 Cents......What say you?
Does the company have any vaible pharma products?
Thanx and have a beautiful weekend!
At least two new upper managements positions (CEO & Chief Med. Officer) are from Transave. http://investor.insmed.com/secfiling...=1104506-10-22 Looks like they're shaking things up, in view of an extension by NASDAQ of delisting until June 2011.
I think there could be a runup to get the stock to $1.00, in the light of the Transwave deal.
Transave's lead product candidate, ARIKACE? (liposomal amikacin for inhalation), is initially being developed for cystic fibrosis (CF) patients with Pseudomonas lung infections and lung infections due to non-TB Mycobacteria (NTM). The combined company intends to initiate phase 3 clinical trials for ARIKACE? in both indications in parallel during the second half of 2011. The results of these trials are expected in the first half of 2013, and will be followed by regulatory filings in the U.S. and Europe for both indications, pending successful trial outcomes. Based on current assumptions, the combined company believes it will have sufficient cash to progress ARIKACE? to commercialization in the U.S.
Transave, which holds worldwide rights to ARIKACE?, was previously granted orphan drug status for the drug candidate from the U.S. Food and Drug Administration (FDA), as well as the European Medicines Agency (EMEA), for the CF indication. The combined company intends to file for orphan status with the FDA and EMEA for the NTM indication in 2011.
It's a Phase III results gamble, but it's still a cheap stock. I think it might be an opportunity to get it up to 1.00. They look determined to do so.
Leave a comment:
-
-
not yet dmk. I'm still healing from my ALXA burn, so more cautious now. But I have been watching LCI and the positive comments. Need to do some DD too. Way too busy with other things. Need a gift of TIME for Christmas!Originally posted by dmk112 View PostBot LCI today at $5.00... dilution taking place but an PDUFA date of Dec 26 is coming up. '
River - did you get in?
But Dec 26 might be Dec 23 or 24 if FDA taking week off after Dec 25. Or the company might get it early and not release until the 27th. P.S. like(!) the new site!
Leave a comment:
-
-
Bec
billy, I saw that too and thought of you. I didn't buy either, but didn't expect the previous news was so bad that they would take this action. Gonna have to start listening to billyjoe!Originally posted by billyjoe View Post
Leave a comment:
-
-
Bot LCI today at $5.00... dilution taking place but an PDUFA date of Dec 26 is coming up. '
River - did you get in?
Leave a comment:
-
-
Insm
River what do you know about INSM Insmed Inc ? Took a beating after an 8K filing with the SEC, BUT INSM is coming alive .....I smell some money can be made at .595 cents per share here on way back up to 70 Cents......What say you?
Does the company have any vaible pharma products?
Thanx and have a beautiful weekend!
Leave a comment:
-
-
River,
This aint no baby but I just got into CELG at 56.50 thinking that concerns over Revlimid are overblown. This will probably turn into a long term hold. I've been waiting for a pullback to get in.
------------billy
Leave a comment:
-
-
If DNDN can get thru $40 it looks promising. I'm still holding some ANX & NVAX.
Watching: XOMA, ACOR
River, anything you got on the radar?
Leave a comment:
-
-
We are DEFINITELY "in the Money". Hey Hey Hey!!! Peanuts and me!!!!Originally posted by peanuts View Post
Leave a comment:
-
-
who'da thunk itOriginally posted by riverbabe View PostYES!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!
heh, want to watch a real short squeeze when this stock trades again after halt????? 9.2% short sold and 5 days at normal volume to cover!!!! YEE HAW!!!!!!



Leave a comment:
-
-
dndn
YES!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!
heh, want to watch a real short squeeze when this stock trades again after halt????? 9.2% short sold and 5 days at normal volume to cover!!!! YEE HAW!!!!!!

Leave a comment:
-

Leave a comment: